Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain
Abstract Primary aim was to assess prevalence and severity of potential and real drug–drug interactions (DDIs) among therapies for COVID-19 and concomitant medications in hospitalized patients with confirmed SARS-CoV-2 infection. The secondary aim was to analyze factors associated with rDDIs. An obs...
Guardado en:
Autores principales: | M. D. Cantudo-Cuenca, Antonio Gutiérrez-Pizarraya, Ana Pinilla-Fernández, Enrique Contreras-Macías, M. Fernández‑Fuertes, F. A Lao‑Domínguez, Pilar Rincón, Juan Antonio Pineda, Juan Macías, Ramón Morillo-Verdugo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b63d4137a2064352b56e7152c9097cb1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders.
por: Jan Wolff, et al.
Publicado: (2021) -
Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
por: Isaac V. Cohen, et al.
Publicado: (2021) -
Drug interactions in the pharmacotherapy of patients included in primary care comprehensive medication management services
por: Hágabo M. SILVA, et al.
Publicado: (2021) -
Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice
por: Byung Jin Choi, et al.
Publicado: (2021) -
Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 Pharmacotherapy
por: Linhu Ye, et al.
Publicado: (2021)